Elevance Health, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Vanguard Capital Management has filed a Schedule 13G reporting a 7.13% beneficial ownership stake in Elevance Health Inc.
NYSE
The Vanguard Group filed an Amendment No. 11 to Schedule 13G for Elevance Health Inc., reporting 0% beneficial ownership due to an internal realignment.
NYSE
SCHEDULE 13G/A: Vanguard Group Discloses 10.13% Passive Stake in Elevance Health
The Vanguard Group has filed an amended Schedule 13G, reporting a 10.13% beneficial ownership stake in Elevance Health Inc., held for passive investment purposes.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.8% Passive Stake in Elevance Health
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.8% beneficial ownership stake in Elevance Health, Inc. as of March 31, 2025.